APPLIED BIOLOGICAL SCIENCES, ENGINEERING Correction for “High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients,” by Yin Tang, Zhuo Wang, Ziming Li, Jungwoo Kim, Yuliang Deng, Yan Li, James R. Heath, Wei Wei, Shun Lu, and Qihui Shi, which appeared in issue 10, March 7, 2017, of Proc Natl Acad Sci USA (114:2544–2549; first published February 21, 2017; 10.1073/pnas.1612229114).
The authors note that the affiliation for Yin Tang, Zhuo Wang, Yuliang Deng, and Qihui Shi should instead appear as Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, 200240, China.
The authors also note that the affiliation for Ziming Li and Shun Lu should instead appear as Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China.
The corrected author and affiliation lines appear below. The online version has been corrected.
Yin Tanga,1, Zhuo Wanga,1, Ziming Lib,1, Jungwoo Kimc,d, Yuliang Denga, Yan Lie, James R. Heathc,d,f, Wei Weic,f,2, Shun Lub,2, and Qihui Shia,2
aKey Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, 200240, China; bShanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China; cNanoSystems Biology Cancer Center, California Institute of Technology, Pasadena, CA 91125; dDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125; eShanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, 200071, China; and fDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095
